Rhode Island Hospital Genetics- Site Number : 840053 — Providence, Rhode Island

Rhode Island Hospital Genetics- Site Number : 840053 is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Rhode Island Hospital Genetics- Site Number : 840053 has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Mucopolysaccharidosis I (MPS I), Gaucher Disease, Cerebroside Lipidosis Syndrome.

Sponsors: Genzyme, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Providence

Browse all research sites in Rhode Island · View every site in Providence

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rhode Island Hospital Genetics- Site Number : 840053?

Rhode Island Hospital Genetics- Site Number : 840053 has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rhode Island Hospital Genetics- Site Number : 840053 conducted?

Rhode Island Hospital Genetics- Site Number : 840053 has 4 clinical trials on record, with 3 currently active. Their work covers Mucopolysaccharidosis I (MPS I), Gaucher Disease, Cerebroside Lipidosis Syndrome.

Is Rhode Island Hospital Genetics- Site Number : 840053 accredited by Crixeo Clinical Trials?

Rhode Island Hospital Genetics- Site Number : 840053 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rhode Island Hospital Genetics- Site Number : 840053?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.